After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $2.75 and fluctuated between $2.8100 as its day high and $2.7017 as its day low. The current market capitalization of Heron Therapeutics Inc is $413.41M. A total of 1.03 million shares were traded on the day, compared to an average of 2.97M shares.
In the most recent transaction, Forbes William P bought 25,000 shares of HRTX for 1.09 per share on Nov 17 ’23. After the transaction, the EVP, Chief Development Officer now owns 79,000 company shares. In a previous transaction on Nov 16 ’23, Collard Craig A bought 150,000 shares at 0.92 per share. HRTX shares that Chief Executive Officer owns now total 186,496.
Among the insiders who bought shares, Duarte Ira acquired of 85,000 shares on Nov 16 ’23 at a per-share price of $0.89. This resulted in the EVP, Chief Financial Officer holding 85,000 shares of HRTX after the transaction. In another insider transaction, Forbes William P bought 50,000 shares at $0.94 per share on Nov 16 ’23. Company shares held by the EVP, Chief Development Officer now total 54,000.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, HRTX has a high of $3.22 and a low of $0.50.
As of this writing, HRTX has an earnings estimate of -$0.09 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.07 per share and a lower estimate of -$0.11. The company reported an EPS of -$0.17 in the last quarter, which was 41.40% higher than expectations of -$0.29.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. HRTX’s latest balance sheet shows that the firm has $157.58M in Cash & Short Term Investments as of fiscal 2021. There were $159.50M in debt and $71.06M in liabilities at the time. Its Book Value Per Share was -$0.23, while its Total Shareholder’s Equity was $77.57M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HRTX is Buy with a score of 4.67.
